David de Leeuw

12PUBLICATIONS
68CO-AUTHORS
Stochastic analysis and modellingHaematological tumoursMedical mycologyMedical virologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 14, 2026
Prognostic value of measuring LSC frequency in AML: a systematic review and meta-analysis.

|Mar 19, 2026
Flow Cytometry-Based Measurable Residual Disease Assessment in Patients With Acute Myeloid Leukemia Receiving Non-Intensive Chemotherapy.

Lukas H Haaksma, Tom Reuvekamp, Kasper J Croese

|Dec 15, 2025
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party.

Jacqueline Cloos, Peter J M Valk, Christian Thiede

|Dec 10, 2025
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia.

Lukas H Haaksma, Raffaele Palmieri, Tom Reuvekamp

|Sep 03, 2025
Computational measurable residual disease assessment in acute myeloid leukemia: a retrospective validation in the HOVON-SAKK-132 trial.

Tim R Mocking, Lukas H Haaksma, Tom Reuvekamp

|Aug 20, 2025
Flow cytometric and molecular MRD in AML: current methods, clinical applications and challenges.

Lukas H Haaksma, Jacqueline Cloos, David C de Leeuw

Pageof 2

Frequent Collaborators

6 joint publications

Jacqueline Cloos

6 joint publications

Lukas H Haaksma

5 joint publications

Tom Reuvekamp

4 joint publications

Thomas Pabst